Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Nov 08, 2021 11:56am
127 Views
Post# 34100210

RE:RE:RE:RE:RE:New documents out on Sedar- Nov 8

RE:RE:RE:RE:RE:New documents out on Sedar- Nov 8 Happy to.  On Page 9 of today's (Nov 8, 2021 Management Information circular - English) :

TSX Conditional Approval

On August 27, 2021, the Corporation received TSX Conditional Approval for the notice of Transaction and the listing of the shares, including the Contingent Shares, to be issued as consideration pursuant to the Transaction, subject to the Corporation fulfilling all of the conditions set out therein



And from that TSX Form 51-102F3 Material Change Report on Sedar Aug 30,2021

8,000,000 common shares contingent upon the achievement of certain milestones (“Milestones”) and StageZero shareholder approval (the “Contingent Shares”). In the event the Milestones are achieved, and the StageZero shareholders do not approve of the issuance of the Contingent Shares, StageZero is obligated to pay to Health Clinics Limited, in lieu of the Contingent Shares, CAD $16,000,000, payable at a rate of 9.5% out of StageZero’s monthly gross revenues. The Contingent Consideration becomes immediately payable in the event of a take-over bid.

------------
The forms have been filed with the TSX.  Depending on the upcoming shareholder vote, once milestones are achieved iit's a just a matter of how they compensate them.  Will it be an issuing of an additional 8 million shares or payout $16 million in payments as outlined.




molotov420 wrote: Can you please explain this to me. The original details of the acquisition showed this:

"8,000,000 common shares contingent upon the achievement of certain milestones ("Milestones") and StageZero shareholder approval (the "Contingent Shares")."

In todays news page 9 in the background section it says:


"The Corporation also agreed to issue an additional 8,000,000 Common Shares (the “Contingent Shares”) to Health Clinics Limited, contingent upon the Corporation’s obtaining shareholder approval of the issuance"

why no mention of milestones this time?! did they forget about the milestones?


<< Previous
Bullboard Posts
Next >>